comparemela.com
Home
Live Updates
Sumitomo Pharma takes license to CRISPR/Cas9 patent portfoli
Sumitomo Pharma takes license to CRISPR/Cas9 patent portfoli
Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics
/PRNewswire/ -- ERS Genomics Limited ("ERS") is pleased to confirm finalization of a license agreement with Sumitomo Pharma Co., Ltd. ("Sumitomo Pharma")...
Related Keywords
Japan ,
Ireland ,
Dublin ,
Sumitomo Pharma ,
Emmanuelle Charpentier ,
Dara Odonnell ,
Eric Rhodes ,
Sumitomo Corporation ,
Summit Pharmaceuticals International Corporation ,
Pharmaceuticals International Corporation ,